Analyze Diet
Australian veterinary journal2011; 89 Suppl 1; 139-142; doi: 10.1111/j.1751-0813.2011.00768.x

Clinical outcomes and virology of equine influenza in a naïve population and in horses infected soon after receiving one dose of vaccine.

Abstract: As part of the control measures of the equine influenza (EI) outbreak, in addition to the strategic use of vaccination to provide buffer zones around infected populations, approval was obtained to vaccinate Thoroughbred racing horses. We review the clinical expression of the disease and virus excretion in a population of racehorses that were exposed to EI approximately 7 days after administration of a single dose of the canarypox-vectored recombinant compared with a similar unvaccinated population of horses at a nearby racetrack. Although this study was undertaken opportunistically and under the difficult field conditions that prevailed during the outbreak, our observations demonstrate that an appropriate vaccine can be effectively used as a disease control measure, even in the face of an outbreak, and therefore should be rapidly implemented as soon as there is evidence of infection in a naïve population.
Publication Date: 2011-07-08 PubMed ID: 21711313DOI: 10.1111/j.1751-0813.2011.00768.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study investigated the effects of a single dose of an equine influenza (EI) vaccine in horses that were exposed to the virus and compared it to a similar unvaccinated horse population. Their findings demonstrated the vaccine can effectively control the disease even amidst an outbreak.

Population and Setting of Study

  • This research was conducted on two populations of Thoroughbred racing horses. One population had been administered a single dose of the canarypox-vectored recombinant vaccine, whilst the other population had not been vaccinated.
  • Both populations were exposed to equine influenza approximately 7 days after the vaccinated group had received the vaccine.

Goals and Objectives of Study

  • The study aimed to assess the clinical manifestation of EI in the vaccinated and unvaccinated populations, also focusing on the virus excretion levels—in essence, the amount of virus the horses were producing and shedding—after exposure.
  • The research endeavored to ascertain the effectiveness of a proactive vaccination strategy during an EI outbreak as a control measure.

Research Methodology

  • The study was conducted opportunistically under the challenging circumstances of an outbreak, which may have influenced the experimental conditions.
  • The researchers obtained approval to vaccinate the test population as a strategic measure to create buffer zones around infected populations, thereby containing and managing the outbreak.

Results of the Study

  • Observations from the study suggested that vaccinating horses with appropriate vaccines could help control EI, even in the face of an ongoing outbreak.
  • This implies that rapid implementation of vaccination protocols is crucial when there is evidence of infection in a naive population.

Cite This Article

APA
Kannegieter NJ, Frogley A, Crispe E, Kirkland PD. (2011). Clinical outcomes and virology of equine influenza in a naïve population and in horses infected soon after receiving one dose of vaccine. Aust Vet J, 89 Suppl 1, 139-142. https://doi.org/10.1111/j.1751-0813.2011.00768.x

Publication

ISSN: 1751-0813
NlmUniqueID: 0370616
Country: England
Language: English
Volume: 89 Suppl 1
Pages: 139-142

Researcher Affiliations

Kannegieter, N J
  • Roseville Equine Clinic, Roseville, NSW, Australia.
Frogley, A
    Crispe, E
      Kirkland, P D

        MeSH Terms

        • Animals
        • Antibodies, Viral / blood
        • Disease Outbreaks / veterinary
        • Horse Diseases / epidemiology
        • Horse Diseases / immunology
        • Horse Diseases / prevention & control
        • Horse Diseases / virology
        • Horses
        • Influenza A Virus, H3N8 Subtype / genetics
        • Influenza A Virus, H3N8 Subtype / immunology
        • Influenza Vaccines / administration & dosage
        • New South Wales / epidemiology
        • Orthomyxoviridae Infections / epidemiology
        • Orthomyxoviridae Infections / immunology
        • Orthomyxoviridae Infections / veterinary
        • Orthomyxoviridae Infections / virology
        • RNA, Viral / chemistry
        • RNA, Viral / genetics
        • Reverse Transcriptase Polymerase Chain Reaction / veterinary
        • Seroepidemiologic Studies
        • Viral Load / veterinary

        Citations

        This article has been cited 6 times.
        1. El-Hage C, Hartley C, Savage C, Watson J, Gilkerson J, Paillot R. Assessment of Humoral and Long-Term Cell-Mediated Immune Responses to Recombinant Canarypox-Vectored Equine Influenza Virus Vaccination in Horses Using Conventional and Accelerated Regimens Respectively. Vaccines (Basel) 2022 May 26;10(6).
          doi: 10.3390/vaccines10060855pubmed: 35746463google scholar: lookup
        2. Spence KL, O'Sullivan TL, Poljak Z, Greer AL. Using a computer simulation model to examine the impact of biosecurity measures during a facility-level outbreak of equine influenza. Can J Vet Res 2018 Apr;82(2):89-96.
          pubmed: 29755187
        3. Paillot R, Marcillaud Pitel C, D'Ablon X, Pronost S. Equine Vaccines: How, When and Why? Report of the Vaccinology Session, French Equine Veterinarians Association, 2016, Reims. Vaccines (Basel) 2017 Dec 4;5(4).
          doi: 10.3390/vaccines5040046pubmed: 29207516google scholar: lookup
        4. Paillot R, El-Hage CM. The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary. Pathogens 2016 Jun 10;5(2).
          doi: 10.3390/pathogens5020042pubmed: 27294963google scholar: lookup
        5. Paillot R. A Systematic Review of Recent Advances in Equine Influenza Vaccination. Vaccines (Basel) 2014 Nov 14;2(4):797-831.
          doi: 10.3390/vaccines2040797pubmed: 26344892google scholar: lookup
        6. Ault A, Zajac AM, Kong WP, Gorres JP, Royals M, Wei CJ, Bao S, Yang ZY, Reedy SE, Sturgill TL, Page AE, Donofrio-Newman J, Adams AA, Balasuriya UB, Horohov DW, Chambers TM, Nabel GJ, Rao SS. Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies. Vaccine 2012 Jun 6;30(26):3965-74.
          doi: 10.1016/j.vaccine.2012.03.026pubmed: 22449425google scholar: lookup